Clofazimine as Elective Treatment for Granulomatous Cheilitis
May 2005 | Volume 4 | Issue 3 | Case Reports | 374 | Copyright © May 2005
Lourdes Rodriguez Fdez.-Freire MD, Amalia Serrano Gotarredona MD, Joes Bernabeu Wittel MD, Agueda Pulpillo Ruiz MD PhD, Rocia Cabrera MD, Manuel Navarrete Ortega MD, Julia Conejo-Mir MD PhD
Abstract
Cheilitis granulomatosa (CG) is a rare, idiopathic inflammatory disorder that usually affects young adults and clinically
is characterized by diffuse, non-tender, soft to firm swelling of one or both lips. A variant of granulomatous cheilitis
is Melkersson-Rosenthal syndrome when associated with facial paralysis and furrowed tongue. Several treatments
have been used with variable success. We report 3 cases of GC treated with oral clofazimine 100 to 200 mg daily for 3
to 6 months obtaining regression of lesions in all treated cases. Hyperpigmentation and elevation of liver enzymes were
observed as side effects.